Compare MIST & CRT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | MIST | CRT |
|---|---|---|
| Founded | 2003 | 1991 |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Oil & Gas Production |
| Sector | Health Care | Energy |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 163.2M | 42.5M |
| IPO Year | N/A | 1992 |
| Metric | MIST | CRT |
|---|---|---|
| Price | $2.36 | $8.21 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 3 | 0 |
| Target Price | ★ $6.33 | N/A |
| AVG Volume (30 Days) | ★ 5.3M | 26.5K |
| Earning Date | 11-12-2025 | 01-01-0001 |
| Dividend Yield | N/A | ★ 9.07% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.74 |
| Revenue | N/A | ★ $5,621,913.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $11.02 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $0.63 | $7.07 |
| 52 Week High | $3.06 | $13.31 |
| Indicator | MIST | CRT |
|---|---|---|
| Relative Strength Index (RSI) | 46.58 | 45.29 |
| Support Level | $2.50 | $7.91 |
| Resistance Level | $2.73 | $8.72 |
| Average True Range (ATR) | 0.26 | 0.23 |
| MACD | -0.02 | -0.11 |
| Stochastic Oscillator | 48.62 | 24.08 |
Milestone Pharmaceuticals Inc is a biopharmaceutical company dedicated to developing and commercializing etripamil for the treatment of cardiovascular medicines. Etripamil is a calcium channel blocker developed as a rapid-onset nasal spray to be administered by the patient to treat episodes of paroxysmal supraventricular tachycardia, or PSVT. The company has an ongoing Phase 2 clinical trial for patients with atrial fibrillation experiencing a rapid ventricular rate (AFib-RVR).
Cross Timbers Royalty Trust is a United States-based trust. The net profits interests are derived from producing royalty, overriding royalty interests, and working interest properties. The underlying properties of the trust include producing properties in Texas, Oklahoma, and New Mexico.